A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution
Status:
Completed
Trial end date:
2020-01-22
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the effectiveness of intranasal budesonide
aqueous spray 256 microgram (mcg)/day for treatment of rhinitis symptoms during times of high
airborne pollution.
Phase:
Phase 4
Details
Lead Sponsor:
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division